Up To 50 Million J&J Vaccine Doses Reportedly Sitting Unused In Baltimore Manufacturing Plant

Up To 50 Million J&J Vaccine Doses Reportedly Sitting Unused In Baltimore Manufacturing Plant

Share to Linkedin Between 30 to 50 million doses of Johnson & Johnson's Covid-19 vaccine are sitting unused in a Baltimore plant that was previously forced to halt its operations due to contamination, according to Reuters, amid a larger crisis of access to vaccines in lower-income countries. A box of Johnson & Johnson's Covid-19 vaccine doses are pictured at Grubb's Pharmacy on Capitol ... [+] Hill. Emergent BioSolutions, the contract manufacturer who produced the doses, is still waiting for a green light from the Food and Drug Administration (FDA) to ship the doses, Reuters reported, citing two unnamed sources. The report notes that pinning down the exact number of doses is difficult since the plant manufactures the raw vaccine itself and does not fill the product into vials. After being forced to halt its operations in April, Emergent has reportedly resumed making new vaccines, but the FDA is yet to inspect and authorize the plant. Forbes has reached out to Johnson & Johnson for a comment on the issue. The report of unused vaccine doses sitting at a plant comes at a time when the World Health Organization and the United Nations have raised concerns about vaccine inequity around the